Leah Prentice

2005 Research Trainee Award,

A potential role for KiSS1 overexpression in tumorigenesis and metastasis of breast cancer and other hormonally responsive tumors

Breast cancer is the second most common cause of death due to cancer among women. One in nine Canadian women will develop breast cancer during her lifetime, and one in 27 will die from the disease. Despite advances in treatment, many women experience metastasis, where the tumor migrates from the original site to other organs or tissues in the body. Leah Prentice is investigating whether the KiSS1 gene has a dual role in breast cancer, which involves increased numbers of the gene driving tumour growth at an early stage, but suppressing metastasis at a later stage. Research indicates KiSS1 prevents metastasis from developing, but it’s unclear how the gene accomplishes this. She is studying the role of the KiSS1 gene in synthesizing and releasing sex hormones like estrogen. Estrogens initially promote the grow th of breast cancers, but this effect is usually lost as the tumor progresses and metastasizes. The research could lead to diagnostic tests to detect breast cancer earlier, and more targeted therapies to treat breast cancer and prevent metastasis. Completed award term, August 2007 Received 2007 MSFHR Trainee Award
Read Leah Prentice’s 2007 Trainee profile

Back to 2005 Research Trainee Awards

 

Research Details

Research Area
Clinical

Partnership Award
Jointly funded with VGH & UBC Hospital Foundation

University/Institution
University of British Columbia

Research Location
Vancouver General Hospital (Vancouver Coastal Health Research Institute)

Faculty/Department
Medicine / Pathology and Laboratory Medicine

Supervisor
Dr. David Huntsman, Assistant Professor, Medicine / Pathology and Laboratory Medicine